SC Filed 2019-10-02 Event — SEC 0000944809-19-000064 →

Opko Health, Inc. → NEOVASC INC

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by Opko Health, Inc.

Filed	Form	Issuer	Stake	Shares
2026-08-07	SCHEDULE 13D	Cocrystal Pharma, Inc.	29.60%	5,692,916	view →
2024-07-05	SC	GeneDx Holdings Corp. WGSWW	—	—	view →
2020-11-19	SC	Cocrystal Pharma, Inc. COCP	—	—	view →
2020-03-10	SC	Cocrystal Pharma, Inc. COCP	—	—	view →
2019-11-22	SC	Cocrystal Pharma, Inc. COCP	—	—	view →
2019-10-23	SC	BioCardia, Inc. BCDA	—	—	view →
2019-10-23	SC	Xenetic Biosciences, Inc. XBIO	—	—	view →
2019-09-30	SC	VBI Vaccines Inc/BC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →